Tevogen Bio Holdings Inc.
TVGNHealthcare|Biotechnology|US
$5.59
+0.03 (+0.54%)
Cash / Share
$0.28
Clinical Trials (1)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT04765449 Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection | Covid19 | P1 | Completed | 30 | Open-label | Cytotoxic T Lymphocytes |